"I am a Senior Product Strategist leading the Roche cancer products, MabThera used in the diseases of non-Hodgkin’s lymphoma (NHL) and GAZYVA used in Chronic Lymphocytic Leukaemia (CLL). My role is to ensure the seamless introduction of these products into the New Zealand health system. These products are important to the health of New Zealanders who have cancer. To ensure health care providers are in the best position to access and use these products optimally, I undertake a number of activities to achieve this outcome. For example, in conjunction with the medical manager, I look to provide ongoing information on our medications. This information is constantly changing as the drug is used more widely and more experience is gained around the world. The sort of information I provide can include updates in the latest medical trial results, including new combinations that have been successful, side effects of the drugs and how to better manage these. It is important to me as a Kiwi that our citizens get the best products, access, support and information possible to achieve the best outcomes for their disease. Working at Roche I look to achieve that every day. " "I am a Senior Product Strategist leading the Roche cancer products, MabThera used in the diseases of non-Hodgkin’s lymphoma (NHL) and GAZYVA used in Chronic Lymphocytic Leukaemia (CLL). My role is to ensure the seamless introduction of these products into the New Zealand health system. These products are important to the health of New Zealanders who have cancer. To ensure health care providers are in the best position to access and use these products optimally, I undertake a number of activities to achieve this outcome. For example, in conjunction with the medical manager, I look to provide ongoing information on our medications. This information is constantly changing as the drug is used more widely and more experience is gained around the world. The sort of information I provide can include updates in the latest medical trial results, including new combinations that have been successful, side effects of the drugs and how to better manage these. It is important to me as a Kiwi that our citizens get the best products, access, support and information possible to achieve the best outcomes for their disease. Working at Roche I look to achieve that every day. "

marketing and sales in pharma